Is Forbes And Company a good stock to invest in?

Forbes And Company can be analyzed on the following key metrics - TTM P/E: 12.85 Sector P/E: 19.81 Dividend Yield: 0% D/E ratio: -

Forbes And Company Share Price

Sector: Healthcare Facilities

Powered by

436.00 +1.80 (0.41%)

1D
5D
1M
3M
6M
1Y
5Y
MAX

Price Range

Today’s Low 430.05

Today’s High 440.00

52 Week Low 264.35

52 Week High 787.95

Key Metrics

Market Cap (In Cr) 558.84
Beta 0.43
Div. Yield (%) 0
P/B 2.52
TTM P/E 12.85
Peg Ratio -
Sector P/E 19.81
D/E 0
Open Price 440
Prev Close 434.2

View All Metrics

Forbes And Company Analysis

Price Analysis

1 Week

2.9%
3 Months

51.53%
6 Month

-8.04%
YTD

-7.17%
1 Year

-32.51%

Risk Meter

51% Low risk
51% Moderate risk
51% Balanced Risk
51% High risk
51% Extreme risk

Forbes And Company News

On January 24, the BSE Sensex surged by 690 points, reaching 71,060, and the Nifty 50 experienced a gain of 215 points, closing at 21,454. (iStock)

Premium

Adani Power, Tata Tech, Vedanta to PNB — 82 firms to declare Q3 results today

4 min read . 25 Jan 2024

Multibagger stock has delivered 350% return to its positional shareholders in YTD time.

Premium

Mauritius-based FII buys stake in this multibagger energy stock

2 min read . 13 Nov 2023

Premium

Multibagger stock announces ₹65 special interim dividend. Check record date

1 min read . 18 Aug 2022

Distressed debt news provider Reorg first reported on the potential bankruptcy. Revlon’s shares plunged 53%, the biggest one-day drop on record, on Friday to close at $2.05.

Premium

Major cosmetics company Revlon set to file for bankruptcy amid heavy debt load

1 min read . 11 Jun 2022

View More News

Forbes And Company Financials

INCOME
BALANCE SHEET
Cashflow

DATE

Annual

Quarterly

Period
2025

Total Revenue
199.23

Selling/ General/ Admin Expenses Total
28.15

Depreciation/ Amortization
0.94

Other Operating Expenses Total
2.04

Total Operating Expense
172.95

Operating Income
26.28

Net Income Before Taxes
40.21

Net Income
122.76

Diluted Normalized EPS
17.33

Period
2024

Total Revenue
125.9

Selling/ General/ Admin Expenses Total
31.79

Depreciation/ Amortization
1.02

Other Operating Expenses Total
2.59

Total Operating Expense
126.02

Operating Income
-0.12

Net Income Before Taxes
21.38

Net Income
-4.46

Diluted Normalized EPS
4.4

Period
2023

Total Revenue
441.98

Selling/ General/ Admin Expenses Total
232.77

Depreciation/ Amortization
26.58

Other Operating Expenses Total
37.94

Total Operating Expense
467.39

Operating Income
-25.41

Net Income Before Taxes
219.12

Net Income
191.95

Diluted Normalized EPS
32.45

Period
2022

Total Revenue
514.73

Selling/ General/ Admin Expenses Total
256.63

Depreciation/ Amortization
40.8

Other Operating Expenses Total
13.16

Total Operating Expense
846.5

Operating Income
-331.77

Net Income Before Taxes
-333.9

Net Income
4229.7

Diluted Normalized EPS
-78.36

Period
2021

Total Revenue
932.42

Selling/ General/ Admin Expenses Total
300.01

Depreciation/ Amortization
67.48

Other Operating Expenses Total
45.59

Total Operating Expense
911.66

Operating Income
20.77

Net Income Before Taxes
-29.94

Net Income
-77.67

Diluted Normalized EPS
2.97

Period
2020

Total Revenue
2730.79

Selling/ General/ Admin Expenses Total
1539.81

Depreciation/ Amortization
97.45

Other Operating Expenses Total
89.5

Total Operating Expense
3009.87

Operating Income
-279.08

Net Income Before Taxes
-337.52

Net Income
-324.6

Diluted Normalized EPS
-145.12

View detailed financials

Forecast

Income Sheet (In Cr) Net Income Vs Revenue

Returns Metrics (In Cr) ROA Vs ROE

Forecast

Balance Sheet Asset vs Liability

Forecast

Cash Flow Operating vs Investing

Forbes And Company Technical

Moving Average SMA

5 Day423.5
10 Day430.41
20 Day414.79

50 Day384.43
100 Day353.36
300 Day462.1

Forbes And Company Peers

Price
Ratio

Name
Latest Price
Change
% Change
52W High
52W Low
Mkt. Cap

Gpt Healthcare
147.1
1.3
0.89
206.5
126.15
1204.57

Kerala Ayurveda
585
47.4
8.82
559
250
703.9

Forbes And Company
436
1.8
0.41
787.95
264.35
558.84

Aashka Hospitals
100
4
4.17
126.55
88.15
234

Lotus Eye Hospital And Institute
71.03
-0.65
-0.91
91
53.44
148.09

Forbes And Company Shareholding

Shareholding Pattern

*Promoter pledging: 72.56%

Shareholding Trend

Shareholding(%) v/s Date

View All

Corporate Actions

Board Meeting
AGM
Dividends
Bonus
Split
Rights

Meeting Date
Purpose

30-Apr-25
Audited Results

11-Feb-25
Quarterly Results

28-Oct-24
Quarterly Results

02-Aug-24
Quarterly Results

29-May-24
Audited Results

25-Jan-24
Quarterly Results

03-Nov-23
Quarterly Results

10-Aug-23
Quarterly Results

26-May-23
Audited Results

02-Feb-23
Quarterly Results

Meeting Date
Announced on
Purpose

27-Jun-25
04-Jun-25
AGM

02-Nov-24
30-Sept-24
POM

29-Aug-24
07-Aug-24
AGM

20-Mar-24
16-Feb-24
POM

31-Oct-23
03-Oct-23
COM

20-Sept-23
18-Aug-23
POM

10-Aug-23
20-Jul-23
AGM

26-Jun-22
25-May-22
POM

13-Aug-21
12-Jul-21
POM

Announced on
Record Date
Ex-Dividend
Dividend Value

16-Aug-22
25-Aug-22
24-Aug-22
65

View All

Company Profile

ABOUT Forbes And Company

Industry Healthcare Facilities
ISIN INE518A01013
BSE Code 502865

Forbes & Company Limited is an India-based company. The Company operates through two segments: coding and industrial automation and real estate. The coding and industrial automation segment includes manufacturing/trading in conventional and automatic marking systems and industrial automation business. The Company caters to the needs of domestic and export markets. The real estate segment is engaged in renting out investment properties and real estate development projects. It is developing Vicinia, the premium residential experience in Powai. Vicinia features eight elegant multi-story towers. It is engaged in developing payment processing and transaction automation solutions. It has established a national network operations and control center, which provides, among other things, remote monitoring, and real-time transaction monitoring services. It is a provider of self-service kiosks in the insurance sector. It manufactures bill payment machines for telecom, power, and utilities.

MANAGEMENT

Pritesh Jhaveri Compliance Officer, Company Secretary
Nirmal Jagawat Whole-time Director

FORBES AND COMPANY SUMMARY

Forbes And Company is trading 0.41% upper at Rs 436.00 as compared to its last closing price. Forbes And Company has been trading in the price range of 440.00 & 430.05. Forbes And Company has given -7.17% in this year & 2.9% in the last 5 days.

Forbes And Company has TTM P/E ratio 12.85 as compared to the sector P/E of 19.81.

Listed peers of Forbes And Company include Gpt Healthcare (0.89%), Kerala Ayurveda (8.82%), Forbes And Company (0.41%) etc.

Forbes And Company has a 73.85% promoter holding & 26.15% public holding.

FAQs about Forbes And Company

Forbes And Company is trading at 436.00 as on 27 Jun, 2025 3:29:34 PM. This is 0.41% upper as compared to its previous closing price of 434.2

The market capitalization of Forbes And Company is 558.84 Cr as on 27 Jun, 2025 3:29:34 PM.

The 52 wk high for Forbes And Company is 787.95 whereas the 52 wk low is 264.35

Forbes And Company can be analyzed on the following key metrics -

TTM P/E: 12.85
Sector P/E: 19.81
Dividend Yield: 0%
D/E ratio: -

Forbes And Company reported a net profit of 122.76 Cr in 2025.

Forbes And Company Quick Links

Equity Quick Links

Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks

Forbes And Company Share Price

Price Range

Key Metrics

Forbes And Company Analysis

Forbes And Company News

Adani Power, Tata Tech, Vedanta to PNB — 82 firms to declare Q3 results today

Mauritius-based FII buys stake in this multibagger energy stock

Multibagger stock announces ₹65 special interim dividend. Check record date

Major cosmetics company Revlon set to file for bankruptcy amid heavy debt load

Forbes And Company Financials

Forecast

Forecast

Forecast

Forbes And Company Technical

Forbes And Company Peers

Forbes And Company Shareholding

Shareholding Pattern

Shareholding Trend

Corporate Actions

Company Profile

ABOUT Forbes And Company

MANAGEMENT

FORBES AND COMPANY SUMMARY

FAQs about Forbes And Company

Wait for it…

Wait for it…

Congratulations!

Subscribe to continue